EPISODE · Oct 10, 2023 · 22 MIN
Home Management of Anaphylaxis: New Understanding and Evolving Perspectives
from The Allergist · host CSACI
"If you're ever thinking, should I use epinephrine or should I not? The answer is always yes, you should use it. It's always safe and it may be life saving.” - Dr. Elissa AbramsVenture into the heart of anaphylaxis matters as Dr. Mariam Hanna welcomes Dr. Elissa Abrams, a recognized expert on severe allergic reactions. They dispel doubts, dismantle misconceptions, and offer an in-depth understanding of anaphylaxis and its evolving treatments.In this episode: •Clarifying the real dangers of anaphylaxis. •Epinephrine: The undeniable champion in allergic emergencies. •The truth about antihistamines and steroids. Do they really help? •Questioning old reliables: Is Benadryl really our best bet? •Biphasic reactions: Getting the facts straight. •Anaphylaxis management: When is home anaphylaxis management an option?Arm yourself with knowledge and prioritize safety when it comes to anaphylaxis. Don't miss these expert revelations. Listen now!Have an idea for the show or a comment, send us a text!Visit the Canadian Society of Allergy and Clinical ImmunologyFind an allergist using our helpful toolFind Dr. Hanna on X, previously Twitter, @PedsAllergyDoc or CSACI @CSACI_caThe Allergist is produced for CSACI by PodCraft Productions
What this episode covers
"If you're ever thinking, should I use epinephrine or should I not? The answer is always yes, you should use it. It's always safe and it may be life saving.” - Dr. Elissa Abrams Venture into the heart of anaphylaxis matters as Dr. Mariam Hanna welcomes Dr. Elissa Abrams, a recognized expert on severe allergic reactions. They dispel doubts, dismantle misconceptions, and offer an in-depth understanding of anaphylaxis and its evolving treatments. In this episode: •Clarifying th...
NOW PLAYING
Home Management of Anaphylaxis: New Understanding and Evolving Perspectives
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m